Order intake rose 2.8% YoY to €1.45 bn, beating consensus €1.42 bn, with 6.4% organic growth.
Revenue hit €1.27 bn in line with forecasts, organic growth 5.3%; EBITDA before restructuring €205.9 m, up 3.9%.
EPS €0.61 missed consensus €0.63; free cash flow turned negative €190.3 m, worsening from -€48.8 m YoY.
Full‑year 2026 outlook reaffirmed: organic sales growth 5‑7%, EBITDA margin 16.6‑17.2%, ROCE 34‑38%.